Wessam S. Abdrabo

Wessam S. Abdrabo

Auto-generated profile, based on publicly available information

Wessam S. Abdrabo

Chemistry Department, Faculty of Science, Benha University, Benha 13518, Egypt

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
SGShaimaa S. Goher
Shaimaa S. Goher
WAWessam S. Abdrabo
Wessam S. Abdrabo
GVGiri Babu Veerakanellore
Giri Babu Veerakanellore
Bahaa ElgendyBahaa Elgendy
Bahaa Elgendy
2,5-Diketopiperazine (2,5-DKP) derivatives represent a family of secondary metabolites widely produced by bacteria, fungi, plants, animals, and marine organisms. Many natural products with DKP scaffolds exhibited various pharmacological activities such as antiviral, antifungal, antibacterial, and antitumor. 2,5-DKPs are recognized as privileged structures in medicinal chemistry, and compounds that incorporate the 2,5-DKP scaffold have been extensively investigated for their anticancer properties. This review is a thorough update on the anti-cancer activity of natural and synthesized 2,5-DKPs from 1997 to 2022. We have explored various aspects of 2,5-DKPs modifications and summarized their structure-activity relationships (SARs) to gain insight into their anticancer activities. We have also highlighted the novel approaches to enhance the specificity and pharmacokinetics of 2,5-DKP-based anticancer agents.